Entrepreneur Paul Conyngham used ChatGPT to help develop a personalized mRNA vaccine that treated his dog's cancer. While headlines framed this as an AI miracle, the technology functioned as a standard productivity tool for research. This case highlights the gap between sensationalist reporting and the actual technical utility of LLMs in biotechnology.